• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量吸入气雾剂的粒径方面

Size aspects of metered-dose inhaler aerosols.

作者信息

Kim C S, Trujillo D, Sackner M A

出版信息

Am Rev Respir Dis. 1985 Jul;132(1):137-42. doi: 10.1164/arrd.1985.132.1.137.

DOI:10.1164/arrd.1985.132.1.137
PMID:4014858
Abstract

The aerodynamic size distribution of several bronchodilator and corticosteroid metered-dose inhaler (MDI) aerosols was estimated in both dry and humid (90% RH) air environments with a six-stage cascade impactor. The distribution of aerosol size that penetrated into a simulated lung model were also measured. The size distributions were approximately log-normal and ranged from 2.4 to 5.5 micron in mass median aerodynamic diameter (MMAD) with geometric standard deviation (GSD) of 1.7 to 2.5 in a dry environment. In humid air, MMAD increased from 1 to 26% above the dry air state, but GSD remained unchanged. The size of aerosol delivered by MDI that penetrated into a simulated lung model fell to 2.4 to 2.8 micron in MMAD (GSD, 1.9 to 2.2). In contrast to aerosols produced by MDI, MMAD of an aerosol of cromolyn sodium powder dispersed by a Spinhaler increased rapidly with increasing humidity, 5.6 +/- 0.3 micron in dry air and 10.1 +/- 0.8 micron in 90% RH air. Finally, the factors influencing size of MDI-delivered aerosols, including formulation, canister pressure, physicochemical properties of propellants, and design of the valve and actuator orifices are discussed. Effective delivery of MDI-generated aerosols into the lung is highly dependent on particle dynamics and jet flow, and no single parameter can produce a unique particle size and jet pattern.

摘要

使用六级串级冲击器在干燥和潮湿(相对湿度90%)的空气环境中估计了几种支气管扩张剂和皮质类固醇定量吸入器(MDI)气雾剂的空气动力学粒径分布。还测量了渗透到模拟肺模型中的气溶胶粒径分布。粒径分布近似对数正态分布,在干燥环境中,质量中值空气动力学直径(MMAD)范围为2.4至5.5微米,几何标准差(GSD)为1.7至2.5。在潮湿空气中,MMAD比干燥空气状态增加了1%至26%,但GSD保持不变。MDI递送并渗透到模拟肺模型中的气溶胶粒径,MMAD降至2.4至2.8微米(GSD为1.9至2.2)。与MDI产生的气溶胶不同,色甘酸钠粉末通过Spinhaler分散产生的气溶胶的MMAD随着湿度增加而迅速增大,在干燥空气中为5.6±0.3微米,在90%相对湿度空气中为10.1±0.8微米。最后,讨论了影响MDI递送气溶胶粒径的因素,包括配方、药罐压力、推进剂的物理化学性质以及阀门和促动器孔口的设计。MDI产生的气溶胶有效递送至肺部高度依赖于颗粒动力学和射流,没有单一参数能够产生独特的粒径和射流模式。

相似文献

1
Size aspects of metered-dose inhaler aerosols.定量吸入气雾剂的粒径方面
Am Rev Respir Dis. 1985 Jul;132(1):137-42. doi: 10.1164/arrd.1985.132.1.137.
2
Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.定量压力吸入气雾剂的气溶胶空气动力学粒径分析:Andersen八级阶式撞击器、新一代药物撞击器和3321型空气动力学粒径分析仪的比较
AAPS PharmSciTech. 2003 Oct 22;4(4):E54. doi: 10.1208/pt040454.
3
A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.溶液计量吸入器所喷射气溶胶的质量中值空气动力学直径的相关方程。
Int J Pharm. 2014 Apr 25;465(1-2):18-24. doi: 10.1016/j.ijpharm.2014.01.039. Epub 2014 Feb 11.
4
Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.以甲氨蝶呤作为模型药物,通过基于氢氟烷烃的定量吸入器进行抗癌药物的吸入给药。
J Aerosol Med. 2002 Fall;15(3):261-70. doi: 10.1089/089426802760292609.
5
Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.将呼气正压装置与使用氯氟烃沙丁胺醇和氢氟烷烃沙丁胺醇的定量吸入器储雾罐系统相结合:对剂量和粒径分布的影响。
Respir Care. 2000 Mar;45(3):320-6.
6
Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency.机械通气模型中沙丁胺醇的给药。定量吸入器与雾化器效率的比较。
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1391-4. doi: 10.1164/ajrccm.152.4.7551401.
7
Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.吸入流速对干粉吸入器(DPI)和定量吸入器(MDI)产品给药特性的影响。
J Aerosol Med. 1996 Summer;9(2):215-26. doi: 10.1089/jam.1996.9.215.
8
Factors influencing the size distribution of aerosols from jet nebulisers.影响喷射式雾化器产生的气溶胶粒径分布的因素。
Thorax. 1983 Oct;38(10):755-9. doi: 10.1136/thx.38.10.755.
9
Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.含二甲醚/丙烷反相微乳液的定量吸入器产生气溶胶的情况。
AAPS PharmSciTech. 2003 Nov 26;4(4):E58. doi: 10.1208/pt040458.
10
Size distribution of chromate paint aerosol generated in a bench-scale spray booth.在小型喷漆房内产生的铬酸盐漆气溶胶的粒径分布。
Ann Occup Hyg. 2005 Jan;49(1):33-45. doi: 10.1093/annhyg/meh080. Epub 2004 Dec 13.

引用本文的文献

1
Correlation Between Dynamic Spray Plume and Drug Deposition of Solution-Based Pressurized Metered-Dose Inhalers.溶液型定量吸入气雾剂的喷雾射流与药物沉积的相关性。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):232-240. doi: 10.1089/jamp.2023.0050. Epub 2024 Jul 15.
2
Water Uptake by Evaporating pMDI Aerosol Prior to Inhalation Affects Both Regional and Total Deposition in the Respiratory System.吸入前蒸发的定量吸入气雾剂(pMDI)的水分摄取会影响呼吸系统中的局部和总沉积。
Pharmaceutics. 2021 Jun 24;13(7):941. doi: 10.3390/pharmaceutics13070941.
3
Comparison of aerosol formulations of formoterol fumarate and budesonide.
富马酸福莫特罗和布地奈德气雾剂剂型的比较。
Indian J Pharm Sci. 2011 May;73(3):282-6. doi: 10.4103/0250-474X.93514.
4
Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors.使用安德森撞击器和马普尔-米勒多级撞击器测定药物载量和药板涂层对市售沙丁胺醇定量吸入器(MDI)颗粒大小分布的影响。
Pharm Res. 1997 Oct;14(10):1437-43. doi: 10.1023/a:1012180924063.
5
Loading effect on particle size measurements by inertial sampling of albuterol metered dose inhalers.沙丁胺醇定量吸入器惯性采样法测量颗粒大小时的负载效应
Pharm Res. 1995 Nov;12(11):1677-81. doi: 10.1023/a:1016253303206.
6
Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives.吸湿性药物气雾剂的行为及疏水性添加剂的影响。
Pharm Res. 1993 Jan;10(1):1-7. doi: 10.1023/a:1018952425107.
7
Bioequivalence of generic aerosol bronchodilators: what are the issues?非专利气雾剂支气管扩张剂的生物等效性:存在哪些问题?
CMAJ. 1989 Nov 1;141(9):883-7.
8
Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers.优化的吸入气雾剂。II. 定量吸入器粒度分析的惯性测试方法。
Pharm Res. 1990 Dec;7(12):1228-33. doi: 10.1023/a:1015973402316.